Division of Gastroenterology, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
Surg Endosc. 2010 Feb;24(2):400-6. doi: 10.1007/s00464-009-0589-x. Epub 2009 Jun 24.
Self-expandable metallic stent (SEMS) for malignant colorectal obstruction is widely used in palliative treatment and as an alternative to surgery. The aims of this study are to evaluate the effectiveness of stent placement for palliative treatment and to identify the predictive factors associated with stent occlusion.
A retrospective analysis was performed in 55 patients who had undergone placement of an uncovered SEMS from February 2004 to April 2007 for palliative treatment of malignant colorectal obstruction with metastatic or locally advanced cancer that was surgically unresectable. We analyzed the technical and clinical outcomes of stent placement, complications related to the procedure, stent patency rate, and predictive factors associated with stent occlusion.
The causes of colorectal obstruction before stent placement were primary colorectal cancer in 42 patients and noncolorectal extrinsic cancer in 13 patients. The initial technical success rate was 98.2%, and the clinical success rate was 94.4%. Complications occurred in 17 patients (30.9%). These included stent occlusion (n = 8), migration (n = 6), bowel perforation (n = 1), stent distortion (n = 1), and fistula formation (n = 1). The mean and median stent patency periods were 184 days [95% confidence interval (CI), 137-230 days] and 141 days (95% CI, 69-213 days), respectively. The degree of expansion 48 h after stent placement was significantly better in the nonocclusion group than in the stent occlusion group. In the multivariate Cox proportional hazard model, insufficient stent expansion (<70%) 48 h after stent placement was significantly associated with an increase in stent occlusion during the follow-up period (odds ratio, 12.55; p = 0.002).
Uncovered SEMS placement is an effective palliative treatment for malignant colorectal obstruction. The degree of stent expansion 48 h after stent placement is significantly associated with the maintenance of stent patency and is a predictive factor for stent occlusion.
自膨式金属支架(SEMS)在恶性结直肠梗阻的姑息治疗中得到广泛应用,是手术治疗的替代方法。本研究旨在评估支架置入术姑息治疗的效果,并确定与支架闭塞相关的预测因素。
对 2004 年 2 月至 2007 年 4 月期间因无法手术切除的转移性或局部晚期不可切除的肿瘤而接受单纯 SEMS 姑息治疗的 55 例恶性结直肠梗阻患者进行回顾性分析。我们分析了支架置入术的技术和临床效果、与该操作相关的并发症、支架通畅率和与支架闭塞相关的预测因素。
支架置入前结直肠梗阻的病因包括原发性结直肠癌 42 例和非结直肠外源性癌症 13 例。初始技术成功率为 98.2%,临床成功率为 94.4%。17 例患者(30.9%)出现并发症,包括支架闭塞 8 例,支架移位 6 例,肠穿孔 1 例,支架变形 1 例,瘘形成 1 例。平均和中位支架通畅时间分别为 184 天(95%可信区间:137-230 天)和 141 天(95%可信区间:69-213 天)。支架放置后 48 小时的扩张程度在无闭塞组明显优于闭塞组。在多变量 Cox 比例风险模型中,支架放置后 48 小时支架扩张不足(<70%)与随访期间支架闭塞风险增加显著相关(比值比:12.55;p=0.002)。
单纯 SEMS 置入术是恶性结直肠梗阻的有效姑息治疗方法。支架放置后 48 小时的扩张程度与支架通畅的维持显著相关,是支架闭塞的预测因素。